Tag: cell therapy

November 30, 2022

AstraZeneca has agreed to acquire Neogene Therapeutics for up to $320 million cash, the companies said Tuesday, in a deal intended to bolster the buyer’s portfolio of cancer-fighting cell therapies. Neogene specializes in discovering, developing, and manufacturing next-generation T-cell receptor […]

November 29, 2022

Once a fringe area of cancer research, cell therapy has exploded over the last decade. Since 2017, several treatments have come to market for blood cancers like leukemia and multiple myeloma, establishing cell therapy as a new class of medicines. […]

November 28, 2022

Brief overview of the CGT landscape A useful starting point is to understand the different types of CGTs. The following are the definition of the three types: Cell therapies: involves the transfer of intact, live cells into a patient to […]

November 7, 2022

At the start of 2021, a crane lifted a shrink-wrapped, elongated structure off a truck flatbed and through a window into an upper floor of Shanghai’s ATLATL Innovation Center. Two months later, that structure was a full-fledged facility for the […]

October 19, 2022

The dark genome – a loose term that covers non-coding regions of the genome that are capable of regulating the expression of genes, previously rather inaccurately referred to as junk DNA – is increasingly being explored by biopharma companies for […]

October 18, 2022

In 2011, cancer cell therapy was closer to science project than treatment. Immunologist Carl June and his colleagues at the University of Pennsylvania were struggling to raise money for a small study of a cell therapy for leukemia. The trial […]

October 14, 2022

Gamma Biosciences, a provider of tools and technologies for cell and gene therapy manufacturing, through their BioMagnetic Solutions business, entered a strategic collaboration with Lonza. Under the multi-year agreement, BioMagnetic Solutions will supply its research and cGMP manufacturing grade FerroSelect […]

October 14, 2022

Showa Denko Materials Co., Ltd. and Kidswell Bio Corp. have entered an agreement to enable process development and clinical manufacturing of cell therapy products using the advantage of SHED*2 (Stem cells from Human Exfoliated Deciduous teeth) which is under development […]

October 12, 2022

FDA’s Center for Biologics Evaluation and Research (CBER) is updating how it manages a growing volume of cellular and gene therapy development programs, seeking added resources and revisions in its oversight of these cutting-edge therapies. Most visible in the elevation […]

October 12, 2022

Cellusion, a Japanese regenerative medicine startup, and Minaris Regenerative Medicine, a global CDMO, announced Letter of Intent (LOI) for the manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative therapy in the U.S. The companies will develop the manufacturing process […]

October 7, 2022

Allogene Therapeutics has begun the first pivotal test of an “off-the-shelf” cell therapy for cancer. The biotechnology company, which has been at the forefront of a push in recent years to develop such treatments, known as allogeneic therapies and derived […]

October 4, 2022

Cellarity has raised $120 million in its third round of venture financing, bringing the company’s total funding raised since launching in 2017 to $293 million. The funds will be used to bring Cellarity’s first research programs into clinical testing for […]

September 28, 2022

The rolling application for exagamglogene autotemcel (exa-cel) – formerly known as CTX001 – will start in November, while a filing in Europe is also expected by the end of the year, said the two partners. The time places exa-cel in […]

September 28, 2022

Genentech is providing $70 million in funding for the multi-year project, which is aimed at identifying “critical success circuits” in T cell therapies used to treat cancer, along with undisclosed milestone payments. A key focus of the alliance is to […]

September 22, 2022

GenScript and Avectas agreed to partner to develop an improved non-viral cell therapy manufacturing process. By combining Avectas’ cell engineering technology with GenScript’s expertise in synthetic long oligo production, the partnership aims to demonstrate a novel and efficient solution for […]

September 20, 2022

GenScript – the life-sciences research tools and services provider – and Avectas, a cell engineering technology company, are partnering to develop an improved non-viral cell therapy manufacturing process. The two companies are focusing on new methods for developing cell therapies […]

September 13, 2022

Ori Biotech, a leader in cell and gene therapy (CGT) manufacturing technologies, and the Cell Therapy Manufacturing Center (CTMC), a joint venture between National Resilience Inc. and MD Anderson Cancer Center, have entered a collaborative partnership to develop industrial manufacturing […]

September 13, 2022

Over the past two centuries, researchers have identified more than 100 different types of blood cancer, while most patients may be familiar with the big three (leukaemia, lymphoma, and melanoma). However, myelodysplastic syndromes and myeloproliferative neoplasms are also prominent types […]

September 5, 2022

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of […]

September 2, 2022

The $20-per-share agreement was a premium of 92% over Forma’s closing share price yesterday, but its stock leaped after the deal was announced from $13.40 to just under the deal price. The biotech went public via a $278 million IPO […]